Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Detalles Bibliográficos
Autores principales: Verhagen, Nathaniel B., Koerber, Nicolas K., Szabo, Aniko, Taylor, Bradley, Wainaina, J. Njeri, Evans, Douglas B., Kothari, Anai N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Aso Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734328/
https://www.ncbi.nlm.nih.gov/pubmed/36479662
http://dx.doi.org/10.1245/s10434-022-12916-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734328/
https://www.ncbi.nlm.nih.gov/pubmed/36479662
http://dx.doi.org/10.1245/s10434-022-12916-z

Ejemplares similares